How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)
Year: 2020
Type: review
Authors: M.C. Arendrup, N. Friberg, M. Mares, G. Kahlmeter, J. Meletiadis, J. Guinea, M.C. Arendrup, J. Meletiadis, J. Guinea, N. Friberg, M. Mares, G. Kahlmeter, C.T. Andersen, S. Arikan-Akdagli, F. Barchiesi, E. Chryssanthou, P. Hamal, H. Järv, N. Klimko, O. Kurzai, K. Lagrou, C. Lass-Flörl, T. Matos, K. Muehlethaler, T.R. Rogers, A. Velegraki, S. Arikan
Institutions: Statens Serum Institut, University of Copenhagen, Rigshospitalet, Helsinki University Hospital, "Ion Ionescu de la Brad" Iasi University of Life Sciences, National and Kapodistrian University of Athens, Erasmus MC, University General Hospital Attikon, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria Gregorio Marañón
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3036059246
